hiv-infections

Documents about hiv-infections

• Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC#834990ClinicalTrials.gov
• Phase III Multicenter, Open-Label, Randomized Trial of Induction Versus Induction Plus Maintenance Foscarnet ( Foscavir ) Therapy for Gastrointestinal CMV Disease#846307ClinicalTrials.gov
• Guidelines for HIV post-exposure prophylaxis: web annex A: summaries of declarations of interest#286821WHO IRIS
• Sex differences in HIV-associated cognitive impairment.#642235eScholarship
• Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)#806773ClinicalTrials.gov
• Evaluation of Pharmacokinetic Drug-drug Interactions Between Hormonal Contraceptives and Doravirine-containing ART Among Women Living With HIV in South Africa#813508ClinicalTrials.gov
• Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected Patients#838842ClinicalTrials.gov
• A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-Risk Populations in Kenya, Africa#903050ClinicalTrials.gov
• Pilot Study of High-Concentration Capsaicin Patches in the Treatment of Painful HIV-Associated Neuropathy#835718ClinicalTrials.gov
• A Study on the Effect of Chemotherapy Combined With Anti-HIV Drugs in HIV-Positive Patients#873814ClinicalTrials.gov
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation#885469ClinicalTrials.gov
• A Phase I, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Compare the Safety and Immunogenicity of Recombinant Envelope Protein rgp120/HIV-1SF2 (BIOCINE) Combined With Seven Adjuvants in Healthy HIV-1 Uninfected Individuals#390951ClinicalTrials.gov
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infection#857957ClinicalTrials.gov
• Therapeutic Intensification of HIV-associated Non-Hodgkin's Lymphoma by Peripheral Blood Cell Transplantation Following Chemotherapy.#893967ClinicalTrials.gov
• Evaluation Of The Performance Of The Nitrate Reductase And Resazurin Titre Assay For The Detection of Mycobacterium Tuberculosis Complex From Sputum In A High Tb and Hiv Setting#908011ClinicalTrials.gov
• Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)#875162ClinicalTrials.gov
• A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults#184809ClinicalTrials.gov
• Improving Prevention Systems to Reduce Disparities for High Priority Populations#828637ClinicalTrials.gov
• Social-Psychological Intervention to Improve Adherence to HAART#874508ClinicalTrials.gov
• Evaluation of Low-dose Darunavir in a Switch Study#891136ClinicalTrials.gov
• Project Minority AIDS Prevention: Reaching Black and Hispanic MSM About PrEP and TasP Using Social Media#895930ClinicalTrials.gov
• Dexamethasone in Cryptococcal Meningitis#899560ClinicalTrials.gov
• Vietnam Cryptococcal Retention in Care Study Version 1.0#900210ClinicalTrials.gov
• Effectiveness of Early or Delayed Addition of Hydroxyurea to a Three-Drug Anti-HIV Drug Combination Including Didanosine, in Advanced HIV Patients Who Failed a First or Second Anti-HIV Triple-Drug Therapy#836882ClinicalTrials.gov
• Assessing healthcare satisfaction and prevalence of diabetes and hypertension among older adults living with HIV in Eastern Uganda: a cross-sectional study.#9905PubMed
• Provision of HIV prevention and care services to farmworkers in sub-Saharan African countries#225369SUNScholar
• Practical approaches and case-based models for reaching men and boys with integrated HIV services#225753WHO IRIS
• Influence of age and co-medication on dolutegravir glucuronidation in paediatric patients#390078SUNScholar
• A Cluster-Randomized Intervention Trial to Improve Quality of Life for HIV-Infected Individuals in Anhui, China#812238ClinicalTrials.gov
• Pilot Project of Virologic and Immunologic Correlates of GALT Immune Reconstitution Following Raltegravir Therapy#861185ClinicalTrials.gov
• Rosuvastatin Versus Pravastatin in HIV Patients Treated With Boosted Protease Inhibitors (PI) (ANRS126)#898115ClinicalTrials.gov
• A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.#28432ClinicalTrials.gov
• A Randomized Trial of L-735,524, An Inhibitor of the HIV Protease Enzyme, and Interleukin-2 in Persons Infected With HIV (NOTE: Only For Patients Who Previously Completed NIAID 93 CC-113)#847245ClinicalTrials.gov
• A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC)#869163ClinicalTrials.gov
• Long-term Follow-up of Long-acting Cabotegravir (CAB LA) for PrEP (Pre-exposure Prophylaxis) in Participants at Risk of Acquiring HIV (Human Immunodeficiency Virus)#900039ClinicalTrials.gov
• Effects of Giving Interleukin-2 (IL-2) Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3#813434ClinicalTrials.gov
• The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV#844534ClinicalTrials.gov
• A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals#256939ClinicalTrials.gov
• A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.#441964ClinicalTrials.gov
• Changes in Triglyceride and Other Lipids (Levels of Fats Found in Blood) When Taking Darunavir Compared to Atazanavir in HIV-infected Patients That Have Never Received Treatment#836786ClinicalTrials.gov
• The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys#256954ClinicalTrials.gov
• Evaluation of Safety and Immunogenicity of a Human Papillomavirus (HPV) Vaccine in Human Immunodeficiency Virus (HIV) Infected Females#266367ClinicalTrials.gov
• GUM Remote Testing v4.0#827879ClinicalTrials.gov
• STI/HIV Prevention Intervention for Adolescents in Singapore#829328ClinicalTrials.gov
• PrEP2Prevent An Online PrEP Navigation and Activation Intervention#851746ClinicalTrials.gov
• Study of the Effectiveness and Safety of Darunavir/Cobicistat (DRV/c) Containing Regimens in Routine Clinical Practice#854496ClinicalTrials.gov
• Prospective Non-Interventional Observational Study of Use of TRIUMEQ and Corresponding Monitoring Measures in Clinical Practice in Germany#861621ClinicalTrials.gov
• A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)#875388ClinicalTrials.gov
• Evaluating the Safety and Efficacy of the VRC01 Antibody in Reducing Acquisition of HIV-1 Infection Among Men and Transgender Persons Who Have Sex With Men#208256ClinicalTrials.gov
• Evaluating the biomedical and behavioral drivers of HIV incidence decline in adolescent girls and young women in Uganda: A mathematical modeling study#260688Spiral